The (benefit) provision for income taxes consisted of the following for the periods presented (in millions of dollars):

	Quarter Ended September 30,					Nine Months Ended September 30,
	2020			2019		2020		2019
Domestic	$	(0.9	)	$	8.5	$	9.6	$	24.7
Foreign		0.2			0.2		0.6		1.1
Total	$	(0.7	)	$	8.7	$	10.2	$	25.8

The income tax (benefit) provision for the quarters ended September 30, 2020 and September 30, 2019 was ($0.7) million and $8.7 million, respectively, reflecting an effective tax rate of 222% and 26%, respectively. The difference between the effective tax rate and the projected blended statutory tax rate for the quarter ended September 30, 2020 was primarily due to a decrease of $0.7 million (or 211% of taxable income) for a change in forecasted earnings and its impact on the annual effective tax rate, partially offset by an increase of $0.1 million (or 22% of taxable income) to the valuation allowance for certain state net operating losses.

The difference between the effective tax rate and the projected blended statutory tax rate for the quarter ended September 30, 2019 was primarily due to an increase of $0.5 million (or 2% of taxable income) related to non-deductible compensation expense.

The income tax provision for the nine months ended September 30, 2020 and September 30, 2019 was $10.2 million and $25.8 million, respectively, reflecting an effective tax rate of 31% and 26% respectively. The difference between the effective tax rate and the projected blended statutory tax rate for the nine months ended September 30, 2020 was primarily due to: (i) an increase of $1.2 million (or 4% of taxable income) related to non-deductible compensation expense and (ii) an increase of $1.3 million (or 4% of taxable income) to the valuation allowance for certain state net operating losses, partially offset by a decrease of $0.7 million (or 2% of taxable income) for the recognition of excess tax benefits from stock-based compensation.

The difference between the effective tax rate and the projected blended statutory tax rate for the nine months ended September 30, 2019 was primarily due to: (i) an increase of $1.5 million (or 2% of taxable income) related to non-deductible compensation expense and (ii) an increase of $0.6 million (or 1% of taxable income) to the valuation allowance for certain state net operating losses, partially offset by a decrease of $0.6 million (or 1% of taxable income) for the recognition of excess tax benefits from stock-based compensation.

Our gross unrecognized benefits relating to uncertain tax positions were $3.9 million and $4.1 million at September 30, 2020 and December 31, 2019, respectively, of which, $0.4 million and $0.9 million would be recorded through our income tax provision and thus impact the effective tax rate at September 30, 2020 and December 31, 2019, respectively, if the gross unrecognized tax benefits were to be recognized.

We do not expect our gross unrecognized tax benefits to significantly change within the next 12 months.

On March 27, 2020, Congress enacted the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act to provide certain relief as a result of the COVID-19 pandemic. We continue to evaluate if and how provisions in the CARES Act will impact our consolidated financial statements.